Oral Bifidobacterium can increase tumor cell control and contributes to interferon (IFN)-γ production by CD8+ tumor-specific T cells, and further increases the activation of intratumoral dendritic cells to improve anti-programmed death ligand (PD-L1) efficacy 60, 62. This evidence concerns the gene IFNG and neoplasm.